Bristol-Myers Squibb Company (BMY)
Interest coverage
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 10,685,000 | -6,432,000 | 9,606,000 | 8,945,000 | 9,432,000 |
| Interest expense | US$ in thousands | 1,510,000 | 1,947,000 | 1,166,000 | 1,232,000 | 1,334,000 |
| Interest coverage | 7.08 | -3.30 | 8.24 | 7.26 | 7.07 |
December 31, 2025 calculation
Interest coverage = EBIT ÷ Interest expense
= $10,685,000K ÷ $1,510,000K
= 7.08
Peer comparison
Dec 31, 2025
Company name
Symbol
Interest coverage
Bristol-Myers Squibb Company
BMY
7.08
AbbVie Inc
ABBV
3.51
Amgen Inc
AMGN
4.27
Biogen Inc
BIIB
8.80
Eli Lilly and Company
LLY
33.16
Gilead Sciences Inc
GILD
0.00
Johnson & Johnson
JNJ
33.55
Merck & Company Inc
MRK
—
Organon & Co
OGN
2.55
Pfizer Inc
PFE
3.82